Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Targeting CD44v6 for fluorescence-guided surgery in head and neck squamous cell carcinoma.

Odenthal J, Rijpkema M, Bos D, Wagena E, Croes H, Grenman R, Boerman O, Takes R, Friedl P.

Sci Rep. 2018 Jul 11;8(1):10467. doi: 10.1038/s41598-018-28059-9.

2.

Part 1: Defining unproven cellular therapies.

Srivastava A, Mason C, Wagena E, Cuende N, Weiss DJ, Horwitz EM, Dominici M.

Cytotherapy. 2016 Jan;18(1):117-9. doi: 10.1016/j.jcyt.2015.11.004. No abstract available.

PMID:
26719202
3.

Positioning a Scientific Community on Unproven Cellular Therapies: The 2015 International Society for Cellular Therapy Perspective.

Dominici M, Nichols K, Srivastava A, Weiss DJ, Eldridge P, Cuende N, Deans RJ, Rasko JE, Levine AD, Turner L, Griffin DL, O'Donnell L, Forte M, Mason C, Wagena E, Janssen W, Nordon R, Wall D, Ho HN, Ruiz MA, Wilton S, Horwitz EM, Gunter KC; 2013–2015 ISCT Presidential Task Force on Unproven Cellular Therapy.

Cytotherapy. 2015 Dec;17(12):1663-6. doi: 10.1016/j.jcyt.2015.10.007. No abstract available.

PMID:
26589750
4.

Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb.

Weigelin B, Bolaños E, Teijeira A, Martinez-Forero I, Labiano S, Azpilikueta A, Morales-Kastresana A, Quetglas JI, Wagena E, Sánchez-Paulete AR, Chen L, Friedl P, Melero I.

Proc Natl Acad Sci U S A. 2015 Jun 16;112(24):7551-6. doi: 10.1073/pnas.1506357112. Epub 2015 Jun 1.

5.

Genetic variants in the serotonin transporter influence the efficacy of bupropion and nortriptyline in smoking cessation.

Quaak M, van Schayck CP, Postma DS, Wagena EJ, van Schooten FJ.

Addiction. 2012 Jan;107(1):178-87. doi: 10.1111/j.1360-0443.2011.03534.x. Epub 2011 Sep 21.

PMID:
21658141
6.

The cost-effectiveness of antidepressants for smoking cessation in chronic obstructive pulmonary disease (COPD) patients.

Van Schayck CP, Kaper J, Wagena EJ, Wouters EF, Severens JL.

Addiction. 2009 Dec;104(12):2110-7. doi: 10.1111/j.1360-0443.2009.02723.x.

PMID:
19922576
7.

Baculovirus complementation restores a novel NDUFAF2 mutation causing complex I deficiency.

Hoefs SJ, Dieteren CE, Rodenburg RJ, Naess K, Bruhn H, Wibom R, Wagena E, Willems PH, Smeitink JA, Nijtmans LG, van den Heuvel LP.

Hum Mutat. 2009 Jul;30(7):E728-36. doi: 10.1002/humu.21037.

PMID:
19384974
8.

The immunogenicity and safety of a nicotine vaccine in smokers and nonsmokers: results of a randomized, placebo-controlled phase 1/2 trial.

Wagena EJ, de Vos A, Horwith G, van Schayck CP.

Nicotine Tob Res. 2008 Jan;10(1):213-8. doi: 10.1080/14622200701704921.

PMID:
18188762
9.

A randomized controlled trial to assess the effects of reimbursing the costs of smoking cessation therapy on sustained abstinence.

Kaper J, Wagena EJ, Willemsen MC, van Schayck CP.

Addiction. 2006 Nov;101(11):1656-61.

PMID:
17034446
10.

Smoking cessation practices of Dutch general practitioners, cardiologists, and lung physicians.

Kotz D, Wagena EJ, Wesseling G.

Respir Med. 2007 Mar;101(3):568-73. Epub 2006 Aug 4.

11.

Encouraging smokers to quit: the cost effectiveness of reimbursing the costs of smoking cessation treatment.

Kaper J, Wagena EJ, van Schayck CP, Severens JL.

Pharmacoeconomics. 2006;24(5):453-64.

PMID:
16706571
12.

Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease.

Wagena EJ, Knipschild PG, Huibers MJ, Wouters EF, van Schayck CP.

Arch Intern Med. 2005 Oct 24;165(19):2286-92.

PMID:
16246996
13.

The need for clinical trials registers: a case study in the field of addiction.

Wagena EJ, Knipschild P.

Addiction. 2005 Oct;100(10):1392-3. No abstract available.

PMID:
16185198
14.

Are patients with COPD psychologically distressed?

Wagena EJ, Arrindell WA, Wouters EF, van Schayck CP.

Eur Respir J. 2005 Aug;26(2):242-8.

15.
16.

Reimbursement for smoking cessation treatment may double the abstinence rate: results of a randomized trial.

Kaper J, Wagena EJ, Willemsen MC, van Schayck CP.

Addiction. 2005 Jul;100(7):1012-20.

PMID:
15955017
17.

The scandal of unfair behaviour of senior faculty.

Wagena EJ.

J Med Ethics. 2005 May;31(5):308. No abstract available.

18.
19.

Should nortriptyline be used as a first-line aid to help smokers quit? Results from a systematic review and meta-analysis.

Wagena EJ, Knipschild P, Zeegers MP.

Addiction. 2005 Mar;100(3):317-26. Review.

PMID:
15733245
20.

Healthcare financing systems for increasing the use of tobacco dependence treatment.

Kaper J, Wagena EJ, Severens JL, Van Schayck CP.

Cochrane Database Syst Rev. 2005 Jan 25;(1):CD004305. Review. Update in: Cochrane Database Syst Rev. 2009;(2):CD004305.

PMID:
15674938
21.

Management of patients with COPD.

Wagena EJ.

Lancet. 2004 Dec 4-10;364(9450):2015-6. No abstract available.

PMID:
15582050
22.

Risk of depression and anxiety in employees with chronic bronchitis: the modifying effect of cigarette smoking.

Wagena EJ, Kant I, van Amelsvoort LG, Wouters EF, van Schayck CP, Swaen GM.

Psychosom Med. 2004 Sep-Oct;66(5):729-34.

PMID:
15385698
23.

The efficacy of smoking cessation strategies in people with chronic obstructive pulmonary disease: results from a systematic review.

Wagena EJ, van der Meer RM, Ostelo RJ, Jacobs JE, van Schayck CP.

Respir Med. 2004 Sep;98(9):805-15. Review.

24.
25.

Smoking cessation for chronic obstructive pulmonary disease.

van der Meer RM, Wagena EJ, Ostelo RW, Jacobs JE, van Schayck CP.

Cochrane Database Syst Rev. 2003;(2):CD002999. Review.

26.

[The efficacy of smoking cessation methods available in the Netherlands: a systematic review based on Cochrane data].

Willemsen MC, Wagena EJ, van Schayck CP.

Ned Tijdschr Geneeskd. 2003 May 10;147(19):922-7. Review. Dutch.

PMID:
12768808
27.

Benefits and risks of pharmacological smoking cessation therapies in chronic obstructive pulmonary disease.

Wagena EJ, Zeegers MP, van Schayck CP, Wouters EF.

Drug Saf. 2003;26(6):381-403. Review.

PMID:
12688831
28.
29.
30.

[Uneasiness about the safety of bupropion as an aid to smoking cessation unjustified ].

Wagena EJ, de Graaf L, Chavannes NH, van Grootheest AC, van Schayck CP.

Ned Tijdschr Geneeskd. 2001 Aug 4;145(31):1489-92. Review. Dutch.

PMID:
11512419
31.

Antidepressants in the treatment of patients with COPD: possible associations between smoking cigarettes, COPD and depression.

Wagena EJ, Huibers MJ, van Schayck CP.

Thorax. 2001 Aug;56(8):587-8. No abstract available.

32.

[Bupropion: an effective new aid for smoking cessation].

Wagena EJ, Zeegers MP, Huibers MJ, Chavannes NH, van Schayck CP.

Ned Tijdschr Geneeskd. 2001 Jan 13;145(2):103-4. Dutch. No abstract available.

PMID:
11225253
33.

Antidepressants for smoking cessation: a promising new approach?

Huibers MJ, Chavannes NH, Wagena EJ, van Schayck CP.

Eur Respir J. 2000 Sep;16(3):379-80. No abstract available.

Supplemental Content

Loading ...
Support Center